2021
DOI: 10.2147/opth.s342947
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Outcomes and Quality of Vision Associated with Bilateral Implantation of a Wavefront Shaping Presbyopia Correcting Intraocular Lens

Abstract: Purpose: To provide normative visual acuity and quality of vision data related to bilateral implantation of a wavefront shaping presbyopia correcting intraocular lens (IOL). Patients and Methods: This was a non-interventional research study of the refraction, visual acuity (VA) and quality of vision achieved after bilateral implantation of a wavefront shaping presbyopia correcting intraocular lens between 3 months and 12 months postsurgery. The manifest refraction, and uncorrected and distance corrected VA at … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
18
0
2

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 20 publications
(22 citation statements)
references
References 23 publications
2
18
0
2
Order By: Relevance
“…Herein, the proportion of eyes implanted with Vivity that achieved a residual refractive error of ±0.5 D of emmetropia was 91.7%, whereas in studies by Gundersen et al and Kohnen et al those proportions were 90% and 90.6%, respectively. 11,12 Refractive outcomes with the enVista IOL in this study were significantly improved compared with those reported in the previous literature. Herein, the proportion of eyes implanted with enVista that achieved a residual refractive error of ±0.5 D of emmetropia was 94.4%, whereas in a study by Heiner et al, this proportion was about 65%.…”
Section: Discussionsupporting
confidence: 41%
“…Herein, the proportion of eyes implanted with Vivity that achieved a residual refractive error of ±0.5 D of emmetropia was 91.7%, whereas in studies by Gundersen et al and Kohnen et al those proportions were 90% and 90.6%, respectively. 11,12 Refractive outcomes with the enVista IOL in this study were significantly improved compared with those reported in the previous literature. Herein, the proportion of eyes implanted with enVista that achieved a residual refractive error of ±0.5 D of emmetropia was 94.4%, whereas in a study by Heiner et al, this proportion was about 65%.…”
Section: Discussionsupporting
confidence: 41%
“…In the construction of the lens, two zones can be distinguished: the transition zone 1 is responsible for stretching the wave front and creating a continuous elongated focus, while the transition zone 2 is responsible for shifting the wave front from hyperopia to short-sighted in order to use all the light energy. It has 1.5 D defocusing and negative asphericity of the anterior surface (−0.2 μm) [ 10 , 11 , 12 ]. Moreover, the extended depth of focus, such as that seen in the Vivity lens, can “forgive” the imperfection of IOL power selection caused by the difficulty in calculating IOL power (especially in patients who have undergone refractive surgery in the past) [ 10 ].…”
Section: Introductionmentioning
confidence: 99%
“…Results appear slightly better than those recently reported (using the same questionnaire and reporting methodology) for a primary EDOF lens with a wavefront shaping technology incorporated. 27 , 28 They also appear better than reported for a diffractive EDOF lens with a different design, again using the same questionnaire and reporting methodology. 29 …”
Section: Discussionmentioning
confidence: 60%